Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13086
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrachayasittikul V.
dc.contributor.authorPingaew R.
dc.contributor.authorWorachartcheewan A.
dc.contributor.authorSitthimonchai S.
dc.contributor.authorNantasenamat C.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:22:17Z-
dc.date.available2021-04-05T03:22:17Z-
dc.date.issued2017
dc.identifier.issn16112156
dc.identifier.other2-s2.0-85019633218
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13086-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85019633218&doi=10.17179%2fexcli2017-309&partnerID=40&md5=6eeb41e54bf47070f70cf31e8a3adb75
dc.description.abstractA series of 2-amino(chloro)-3-chloro-1,4-naphthoquinone derivatives (1-11) were investigated for their aromatase inhibitory activities. 1,4-Naphthoquinones 1 and 4 were found to be the most potent compounds affording IC50 values 5.2 times lower than the reference drug, ketoconazole. A quantitative structure-activity relationship (QSAR) model provided good predictive performance (R2 CV = 0.9783 and RMSECV = 0.0748) and indicated mass (Mor04m and H8m), electronegativity (Mor08e), van der Waals volume (G1v) and structural information content index (SIC2) descriptors as key descriptors governing the activity. To investigate the effects of structural modifications on aromatase inhibitory activity, the model was employed to predict the activities of an additional set of 39 structurally modified compounds constructed in silico. The prediction suggested that the 2,3-disubstitution of 1,4-naphthoquinone ring with halogen atoms (i.e., Br, I and F) is the most effective modification for potent activity (1a, 1b and 1c). Importantly, compound 1b was predicted to be more potent than its parent compound 1 (11.90-fold) and the reference drug, letrozole (1.03-fold). The study suggests the 1,4-naphthoquinone derivatives as promising compounds to be further developed as a novel class of aromatase inhibitors. © 2017, Leibniz Research Centre for Working Environment and Human Factors. All rights reserved.
dc.subject1,4 naphthoquinone derivative
dc.subject2 amino(chloro) 3 chloro 1,4 naphthoquinone derivative
dc.subjectcompound 1
dc.subjectcompound 10
dc.subjectcompound 11
dc.subjectcompound 2
dc.subjectcompound 3
dc.subjectcompound 4
dc.subjectcompound 5
dc.subjectcompound 6
dc.subjectcompound 7
dc.subjectcompound 8
dc.subjectcompound 9
dc.subjectdoxorubicin
dc.subjectketoconazole
dc.subjectletrozole
dc.subjectunclassified drug
dc.subjectArticle
dc.subjectcomputer model
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectdrug determination
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC50
dc.subjectquantitative structure activity relation
dc.titleAromatase inhibitory activity of 1,4-naphthoquinone derivatives and QSAR study
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationEXCLI Journal. Vol 16, (2017), p.714-726
dc.identifier.doi10.17179/excli2017-309
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.